Comparisons · FAQ
Semaglutide vs tirzepatide: Who may qualify for weight management treatment?
Short answer
For approved adult weight management products, eligibility generally starts at a body mass index of 30, or 27 with a weight-related health condition. These numbers alone do not establish eligibility. A physician licensed in your state must review your health history, medicines, and the risks of semaglutide or tirzepatide.
Approved adult weight management products generally are intended for people with a body mass index, or BMI, of 30 or higher. They may also be used at a BMI of 27 or higher when a person has a weight-related condition, such as high blood pressure or type 2 diabetes. Meeting a BMI cutoff does not mean a prescription is appropriate.
Both drugs have important limits. They should not be used by people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2, also called MEN 2. A past serious allergic reaction to the drug is another reason not to use it.
Tell your physician about pancreatitis, gallbladder disease, severe stomach-emptying problems, kidney concerns, or diabetic eye disease. These issues may affect the choice or require closer review.
Pregnancy, plans for pregnancy, and breastfeeding also need discussion. At Verra, a physician licensed in your state reviews these details and decides whether either treatment is appropriate for you.
Sources
Written by the Verra clinical team · Medical review pending
General information, not medical advice. If you're in crisis, call or text 988.
Related guides
Related questions
- Semaglutide vs tirzepatide: What is the main difference?
- Semaglutide vs tirzepatide: Which leads to more weight loss?
- Semaglutide vs tirzepatide: How do side effects compare?
- Semaglutide vs tirzepatide: How do weekly injections and oral options differ?
- Semaglutide vs tirzepatide: How long does it take to notice changes?